skip to content
FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008. Preview this item
ClosePreview this item
Checking...

FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.

Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Publisher: Washington : U.S. G.P.O., 2008.
Edition/Format:   eBook : Document : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Print version:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
FDA's foreign drug inspection program
iii, 262 p.
(DLC) 2009438953
(OCoLC)466878510
Microfiche:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
FDA's foreign drug inspection program
iii, 262 p.
(OCoLC)609408377
Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
OCLC Number: 466899486
Notes: Title from title screen (viewed on Nov. 18, 2009).
Paper version available for sale by the Supt. of Docs., U.S.G.P.O.
"Serial no. 110-107."
Description: 1 online resource (iii, 262 pages) : illustrations, maps
Contents: Drug safety: preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program --
Drug safety: preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers --
Medical devices: challenges for FDA in conducting manufacturer inspections --
Drug tied to China had contaminant, FDA says --
Heparin is now suspected in 62 fatalities across U.S. --
US watchdog critical of FDA foreign drug oversight.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/466899486> # FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
   library:oclcnum "466899486" ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/2517253238#Place/washington> ; # Washington
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
   schema:about <http://id.worldcat.org/fast/968210> ; # Imports--Inspection
   schema:about <http://id.loc.gov/authorities/classification/KF27> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/2517253238#Topic/imports_inspection_united_states> ; # Imports--Inspection--United States
   schema:about <http://viaf.org/viaf/151271988> ; # United States. Food and Drug Administration.
   schema:about <http://id.worldcat.org/fast/898823> ; # Drugs--Inspection
   schema:about <http://experiment.worldcat.org/entity/work/data/2517253238#Organization/united_states_food_and_drug_administration> ; # United States. Food and Drug Administration.
   schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
   schema:about <http://experiment.worldcat.org/entity/work/data/2517253238#Topic/drugs_inspection_united_states> ; # Drugs--Inspection--United States
   schema:bookFormat schema:EBook ;
   schema:creator <http://viaf.org/viaf/126693225> ; # United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
   schema:datePublished "2008" ;
   schema:description "Drug safety: preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program -- Drug safety: preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers -- Medical devices: challenges for FDA in conducting manufacturer inspections -- Drug tied to China had contaminant, FDA says -- Heparin is now suspected in 62 fatalities across U.S. -- US watchdog critical of FDA foreign drug oversight."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/2517253238> ;
   schema:genre "National government publication"@en ;
   schema:genre "Government publication"@en ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/609408377> ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/466878510> ;
   schema:name "FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008."@en ;
   schema:productID "466899486" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/466899486#PublicationEvent/washington_u_s_g_p_o_2008> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/2517253238#Agent/u_s_g_p_o> ; # U.S. G.P.O.
   schema:url <http://catalog.hathitrust.org/api/volumes/oclc/466878510.html> ;
   schema:url <http://books.google.com/books?id=7jYWmfziCAUC> ;
   schema:url <http://purl.access.gpo.gov/GPO/LPS116729> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/466899486> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2517253238#Organization/united_states_food_and_drug_administration> # United States. Food and Drug Administration.
    a schema:Organization ;
   schema:name "United States. Food and Drug Administration." ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
   schema:name "United States." ;
    .

<http://id.worldcat.org/fast/898823> # Drugs--Inspection
    a schema:Intangible ;
   schema:name "Drugs--Inspection"@en ;
    .

<http://id.worldcat.org/fast/968210> # Imports--Inspection
    a schema:Intangible ;
   schema:name "Imports--Inspection"@en ;
    .

<http://viaf.org/viaf/126693225> # United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
    a schema:Organization ;
   schema:name "United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations." ;
    .

<http://viaf.org/viaf/151271988> # United States. Food and Drug Administration.
    a schema:Organization ;
   schema:name "United States. Food and Drug Administration." ;
    .

<http://www.worldcat.org/oclc/466878510>
    a schema:CreativeWork ;
   rdfs:label "FDA's foreign drug inspection program" ;
   schema:description "Print version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/466899486> ; # FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
    .

<http://www.worldcat.org/oclc/609408377>
    a schema:CreativeWork ;
   rdfs:label "FDA's foreign drug inspection program" ;
   schema:description "Microfiche:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/466899486> ; # FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
    .

<http://www.worldcat.org/title/-/oclc/466899486>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <http://www.worldcat.org/oclc/466899486> ; # FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
   schema:dateModified "2017-12-23" ;
   void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.